LFG
IDXX icon

Lazard Frères Gestion’s Idexx Laboratories IDXX Stock Holding History

Lazard Frères Gestion’s Portfolio IDXX Stock Details IDXX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$39.8M Buy
75,574
+8,287
+12% +$4.65M 0.69% 40
2026
Q1 		$37.8M Buy
67,287
+4,290
+7% +$2.75M 0.75% 42
2025
Q4 		$42.6M Sell
62,997
-15,702
-20% -$10.7M 0.77% 39
2025
Q3 		$50.3M Sell
78,699
-12,205
-13% -$7.41M 0.96% 35
2025
Q2 		$48.8M Buy
90,904
+9,671
+12% +$4.62M 1.02% 32
2025
Q1 		$34.1M Buy
81,233
+32,110
+65% +$13.9M 0.83% 39
2024
Q4 		$20.3M Buy
+49,123
New +$21.5M 0.41% 44

Other funds holding IDXX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
BAMCO Inc
BAMCO Inc New York $66.6B AUM 7.35% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
Arrowstreet Capital
Arrowstreet Capital Boston, Massachusetts $225B AUM 49.49% 1-Year Est. Return

Lazard Frères Gestion's IDXX Position: Q2 2026 in Review

Lazard Frères Gestion increased its Idexx Laboratories (IDXX) stake by 12% in Q2 2026, buying an estimated $4.65M and bringing the position to 75,574 shares worth $39.8M. The position accounts for 0.69% of the portfolio, ranked #40.

Lazard Frères Gestion first reported a position in IDXX in Q4 2024 and has held it in 7 quarters since. The position peaked at $50.3M in Q3 2025. 1,302 funds tracked by Wall St. Rank hold IDXX as of Q2 2026.

  • Lazard Frères Gestion held 75,574 shares of Idexx Laboratories worth $39.8M as of Q2 2026.
  • Lazard Frères Gestion bought 8,287 Idexx Laboratories shares in Q2 2026, an estimated $4.65M.
  • Idexx Laboratories made up 0.69% of Lazard Frères Gestion's portfolio in Q2 2026, its #40 holding.
  • Lazard Frères Gestion first reported a position in Idexx Laboratories in Q4 2024 and has held it in 7 quarters since.
  • Lazard Frères Gestion's Idexx Laboratories position peaked at $50.3M in Q3 2025.
  • 1,302 funds tracked by Wall St. Rank held Idexx Laboratories as of Q2 2026.

Based on Lazard Frères Gestion's 13F filing for Q2 2026, filed 6 Aug 2026.